Literature DB >> 3919521

Renin release during controlled hypotension with sodium nitroprusside, nitroglycerin and adenosine: a comparative study in the dog.

M Lagerkranser, A Sollevi, L Irestedt, B Tidgren, M Andreen.   

Abstract

The haemodynamic effects of i.v. infusions of sodium nitroprusside (SNP), nitroglycerin (TNG), and adenosine were studied in dogs in parallel with quantitative determinations of plasma renin activity (PRA) by radioimmunoassay. The drugs were given for controlled hypotension, and the mean arterial blood pressure (MABP) was decreased to approximately 50 mmHg (6.7 kPa). Arterial blood samples for PRA were collected at 10-min intervals. During the last interval the dogs were subjected to haemorrhagic shock. SNP-induced hypotension could be maintained only with a stepwise increase in infusion rate, from 11.8 to 16.0 micrograms X kg-1 X min-1 (P less than 0.05). TNG could not produce the desired blood pressure level, but gradually increasing doses induced a gradually decreasing MABP (80-60 mmHg) (10.7-8.0 kPa). During adenosine-induced hypotension, a perfectly stable blood pressure level was maintained without dose adjustments. Both SNP and TNG induced blood pressure-dependent increases in PRA, while no changes in PRA were seen during adenosine-induced hypotension. Nor could haemorrhagic shock, which induced further increases in PRA during SNP- and TNG-induced hypotension, alter PRA during adenosine infusions. We conclude that adenosine differs markedly from conventional hypotensive drugs such as SNP and TNG with respect to stability of action and dose requirements, and that this stability is related to an inhibited increase in renin release.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3919521     DOI: 10.1111/j.1399-6576.1985.tb02157.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  9 in total

1.  Adenosine in heart and lung disease. Proceedings of the first Cardiothoracic Institute Workshop. 30 March 1988, London. Abstracts.

Authors: 
Journal:  Postgrad Med J       Date:  1988-10       Impact factor: 2.401

2.  Adenosine: a new antihypertensive agent during pheochromocytoma removal.

Authors:  S Gröndal; L Bindslev; A Sollevi; B Hamberger
Journal:  World J Surg       Date:  1988-10       Impact factor: 3.352

3.  Epac is required for exogenous and endogenous stimulation of adenosine A2B receptor for inhibition of angiotensin II-induced collagen synthesis and myofibroblast differentiation.

Authors:  Sarawuth Phosri; Kwanchai Bunrukchai; Warisara Parichatikanond; Vilasinee H Sato; Supachoke Mangmool
Journal:  Purinergic Signal       Date:  2018-01-10       Impact factor: 3.765

4.  Effects of KRN2391-induced hypotension on the endocrine system and carbohydrate metabolism in halothane-anesthetized dogs.

Authors:  Shohei Takeda; Hiroki Iizuka; Hiroshi Miyamoto; Teruaki Tomaru
Journal:  J Anesth       Date:  1998-06       Impact factor: 2.078

Review 5.  It is time to ask what adenosine can do for cardioprotection.

Authors:  M Kitakaze; M Hori
Journal:  Heart Vessels       Date:  1998       Impact factor: 2.037

Review 6.  A Comprehensive Review of the Pleiotropic Effects of Ticagrelor.

Authors:  Jeffrey Triska; Neil Maitra; Matthew R Deshotels; Faris Haddadin; Dominick J Angiolillo; Gemma Vilahur; Hani Jneid; Dan Atar; Yochai Birnbaum
Journal:  Cardiovasc Drugs Ther       Date:  2022-08-24       Impact factor: 3.947

7.  Comparison of the haemodynamic effects of adenosine monophosphate with sodium nitroprusside in a canine model of acute global left ventricular dysfunction.

Authors:  B A Finegan; A S Clanachan
Journal:  Br J Pharmacol       Date:  1991-07       Impact factor: 8.739

8.  Effects of sodium nitroprusside (MR7S1) and nitroglycerin on the systemic, renal, cerebral, and coronary circulation of dogs anesthetized with enflurane.

Authors:  M Hamaguchi; T Ishibashi; N Katsumata; A Mitomi; S Imai
Journal:  Cardiovasc Drugs Ther       Date:  1992-12       Impact factor: 3.727

9.  Transcriptomic profiling of the four adenosine receptors in human leukocytes of heart failure patients.

Authors:  Manuela Cabiati; Raffaele Caruso; Alessandro Verde; Laura Sabatino; Maria-Aurora Morales; Silvia Del Ry
Journal:  Biomed Res Int       Date:  2013-07-08       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.